Close

Ligand Pharma (LGND) Reports FDA Approval of Promacta/Revolade sNDA

August 27, 2014 8:46 AM EDT Send to a Friend
Ligand Pharma (Nasdaq: LGND) announced that its partner GlaxoSmithKline (NYSE: GSK) plc has received approval of a supplemental New Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login